ENST00000710905.2:n.639A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000710905.2(MIR29B2CHG):​n.639A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 469,686 control chromosomes in the GnomAD database, including 10,319 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3079 hom., cov: 32)
Exomes 𝑓: 0.20 ( 7240 hom. )

Consequence

MIR29B2CHG
ENST00000710905.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.428

Publications

16 publications found
Variant links:
Genes affected
MIR29B2CHG (HGNC:32018): (MIR29B2 and MIR29C host gene)
MIR29B2 (HGNC:31620): (microRNA 29b-2) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR29B2CHGNR_135298.1 linkn.980A>G non_coding_transcript_exon_variant Exon 5 of 5
MIR29B2CHGNR_135299.1 linkn.1165A>G non_coding_transcript_exon_variant Exon 6 of 6
MIR29B2NR_029518.1 linkn.-81A>G upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIR29B2CHGENST00000710905.2 linkn.639A>G non_coding_transcript_exon_variant Exon 5 of 5
MIR29B2CHGENST00000710901.1 linkn.662+3401A>G intron_variant Intron 5 of 5
MIR29B2CHGENST00000710902.1 linkn.569+13325A>G intron_variant Intron 4 of 4

Frequencies

GnomAD3 genomes
AF:
0.195
AC:
29646
AN:
151980
Hom.:
3072
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.176
Gnomad AMI
AF:
0.113
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.140
Gnomad EAS
AF:
0.00617
Gnomad SAS
AF:
0.143
Gnomad FIN
AF:
0.221
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.215
Gnomad OTH
AF:
0.171
GnomAD4 exome
AF:
0.202
AC:
64090
AN:
317588
Hom.:
7240
Cov.:
0
AF XY:
0.196
AC XY:
35043
AN XY:
178514
show subpopulations
African (AFR)
AF:
0.174
AC:
1542
AN:
8862
American (AMR)
AF:
0.301
AC:
8984
AN:
29858
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
1152
AN:
8842
East Asian (EAS)
AF:
0.00599
AC:
73
AN:
12188
South Asian (SAS)
AF:
0.163
AC:
9396
AN:
57718
European-Finnish (FIN)
AF:
0.217
AC:
6462
AN:
29794
Middle Eastern (MID)
AF:
0.123
AC:
318
AN:
2586
European-Non Finnish (NFE)
AF:
0.218
AC:
33554
AN:
153810
Other (OTH)
AF:
0.187
AC:
2609
AN:
13930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
2294
4588
6883
9177
11471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.195
AC:
29655
AN:
152098
Hom.:
3079
Cov.:
32
AF XY:
0.193
AC XY:
14382
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.176
AC:
7307
AN:
41486
American (AMR)
AF:
0.242
AC:
3694
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
486
AN:
3472
East Asian (EAS)
AF:
0.00599
AC:
31
AN:
5174
South Asian (SAS)
AF:
0.142
AC:
688
AN:
4830
European-Finnish (FIN)
AF:
0.221
AC:
2327
AN:
10534
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.215
AC:
14617
AN:
67996
Other (OTH)
AF:
0.169
AC:
357
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1215
2430
3645
4860
6075
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.202
Hom.:
378
Bravo
AF:
0.197
Asia WGS
AF:
0.0790
AC:
278
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
9.0
DANN
Benign
0.81
PhyloP100
0.43

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56075814; hg19: chr1-207975949; COSMIC: COSV66080695; API